sábado, 26 de marzo de 2016

Medicare letters to curb overprescribing of controlled substances had no detectable effect on providers. | AHRQ Patient Safety Network

Medicare letters to curb overprescribing of controlled substances had no detectable effect on providers. | AHRQ Patient Safety Network



Giving peer comparisons to clinicians who frequently prescribe controlled substances had no impact on prescribing practices.
Health Aff (Millwood). 2016;35:471-479.



PSNet email header



  • Study
  •  
  • Published March 2016

Medicare letters to curb overprescribing of controlled substances had no detectable effect on providers.

    Overprescribing of opioids is a serious and worsening problem. In the United States, deaths from opioid overdoses have more than quadrupled over the past decade. Providing peer comparisons has been shown to reduce other instances of medical care overuse, such asinappropriate antibiotic prescriptions. In this study, health care providers who very frequently prescribed Schedule II controlled substances (the highest risk category for which a prescription is still legal) were randomized to receive a letter showing their prescription practices compared to their peers. There was no evidence that the letters had any impact on prescribing behaviors. The authors describe ongoing efforts to redesign the letters with the hope to enhance their influence on physicians. A past WebM&M commentary discussed best practices for opioid prescribing.








    View More

    No hay comentarios: